Emcure Pharmaceuticals informs about change in management

22 May 2025 Evaluate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), read with Schedule III of aforesaid regulation and SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11 November, 2024; Emcure Pharmaceuticals has informed that, based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company at their meeting held on May 22, 2025, has approved the re-appointment of Dr. Mukund Gurjar (DIN: 00026843) as Whole-time Director of the Company for a further period of one (1) year commencing from August 28, 2025, subject to approval of Members in the ensuing Annual General Meeting of the Company. The particulars of the disclosure required under Regulation 30 and Part A of Schedule III of the SEBI Listing Regulations are provided in Annexure A enclosed. 

The above information is a part of company’s filings submitted to BSE.

Emcure Pharma Share Price

1395.15 -9.10 (-0.65%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×